Chimin(SH:603222) 2 1 Shi Ji Jing Ji Bao Dao·2025-03-28 10:15Core Viewpoint - Jimin Health (603222.SH) is taking swift actions to address internal issues, including the dismissal of a vice president involved in a scandal and the announcement of a share buyback plan to restore investor confidence [1][5]. Group 1: Company Actions - The board of Jimin Health unanimously approved the dismissal of Vice President He Qinghong, who is no longer holding any position in the company, and this action is not expected to affect normal operations [1]. - Following the scandal, Jimin Health announced a share buyback plan, intending to repurchase shares worth between 100 million yuan and 200 million yuan, with a maximum buyback price of 10.00 yuan per share [5]. Group 2: Scandal Details - He Qinghong is under investigation for allegedly forging company seals, which led to the signing of unauthorized supplementary agreements with distributors, requiring the company to fulfill return and refund obligations [3]. - The sales model managed by He Qinghong's team involved a prepayment system, with total sales amounting to approximately 117 million yuan for 2023 and 2024 [3]. Group 3: Market Reaction - Jimin Health's stock price reacted negatively to the news, closing at a limit down of 6.03 yuan per share on March 27, down from 6.70 yuan the previous day, but saw a slight recovery on March 28, closing at 6.07 yuan [4].